An Emerging Markets Sponsored Commentary

Significant news release from diversified health and wellness; beverage and natural products company, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) last week as the Company appointed Melise Panetta as its new President. Chief among Panetta’s resume stops is a tenure as an executive at beverage giant PepsiCo.

We think this is a very notable event. Let’s show you why.

With BevCanna’s recent transformative acquisition(s), its evident CPG and cannabis-infused beverages and natural products are going to be significant driving factors going forward. Adding an executive of Panetta’s standing can be highly catalytic to growth… and notoriety.

Let’s start with the latter. Adding Panetta, a leading consumer packaged goods (“CPG”) executive who has held senior and executive roles at global companies such as General Mills, PepsiCo, and S.C. Johnson says a lot about the quality and growth prospect of the organization. Ms. Panetta has seen beverage and CPG companies of the highest order and for her to join BevCanna at this stage, shows how she views its potential trajectory.

By inking Panetta, we believe, BevCanna gets a myriad of leadership benefits coming to the big chair as well as a real mark of notoriety.

Factor in that she has broad experience in the cannabis sector as well and the implied benefits grow clearer.

The release is chocked full of nuggets that we like: “ Melise joined the team in the fall to build our international commercial strategy ” or “ We’ve already capitalized on her significant expertise to accelerate our strategic planning for the newly amalgamated company .”

And of course, this hefty release doesn’t touch on what Ms. Panetta could hypothetically do with her industry Rolodex via deals with larger partners and/or even recruiting for the BevCanna team.

Again, 100% hypothetical but this is what presidents of companies often do.
Nonetheless, in this important release from BevCanna perhaps the most important line comes from the new president herself who says unequivocally that “ This is a truly transformative time for BevCanna.”

About The Emerging Markets Report:

The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at

Must Read OTC Markets/SEC policy on stock promotion and investor protection

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.

EMC has been paid $350,000 by BevCanna Enterprises Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial.

Emerging Markets Consulting, LLC
Florida Office
390 North Orange Ave Suite 2300
Orlando Fl, 32801

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less